These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20065148)

  • 21. Angiotensin II-induced non-alcoholic fatty liver disease is mediated by oxidative stress in transgenic TG(mRen2)27(Ren2) rats.
    Wei Y; Clark SE; Morris EM; Thyfault JP; Uptergrove GM; Whaley-Connell AT; Ferrario CM; Sowers JR; Ibdah JA
    J Hepatol; 2008 Sep; 49(3):417-28. PubMed ID: 18486983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation.
    Siragy HM; Xue C; Abadir P; Carey RM
    Hypertension; 2005 Jan; 45(1):133-7. PubMed ID: 15534073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts.
    Gul R; Alsalman N; Bazighifan A; Alfadda AA
    J Pharm Pharmacol; 2021 Oct; 73(11):1520-1529. PubMed ID: 34453839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury.
    Fiebeler A; Schmidt F; Müller DN; Park JK; Dechend R; Bieringer M; Shagdarsuren E; Breu V; Haller H; Luft FC
    Hypertension; 2001 Feb; 37(2 Pt 2):787-93. PubMed ID: 11230374
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipoic acid supplementation prevents angiotensin II-induced renal injury.
    Mervaala E; Finckenberg P; Lapatto R; Müller DN; Park JK; Dechend R; Ganten D; Vapaatalo H; Luft FC
    Kidney Int; 2003 Aug; 64(2):501-8. PubMed ID: 12846745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valsartan abolishes most of the memory-improving effects of intracerebroventricular angiotensin II in rats.
    Braszko JJ
    Clin Exp Hypertens; 2005 Nov; 27(8):635-49. PubMed ID: 16303640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
    Fischer R; Dechend R; Gapelyuk A; Shagdarsuren E; Gruner K; Gruner A; Gratze P; Qadri F; Wellner M; Fiebeler A; Dietz R; Luft FC; Muller DN; Schirdewan A
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1242-53. PubMed ID: 17416596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The angiotensin type 1 receptor antagonist valsartan attenuates pathological ventricular hypertrophy induced by hyperhomocysteinemia in rats.
    Kassab S; Garadah T; Abu-Hijleh M; Golbahar J; Senok S; Wazir J; Gumaa K
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):206-11. PubMed ID: 17318789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Entacapone protects from angiotensin II-induced inflammation and renal injury.
    Helkamaa T; Finckenberg P; Louhelainen M; Merasto S; Rauhala P; Lapatto R; Cheng ZJ; Reenilä I; Männistö P; Müller DN; Luft FC; Mervaala EM
    J Hypertens; 2003 Dec; 21(12):2353-63. PubMed ID: 14654757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.
    Matsushita K; Wu Y; Okamoto Y; Pratt RE; Dzau VJ
    Hypertension; 2006 Dec; 48(6):1095-102. PubMed ID: 17060512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factor-kappaB-dependent pathway in rat preadipocytes.
    Tsuchiya K; Yoshimoto T; Hirono Y; Tateno T; Sugiyama T; Hirata Y
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E771-8. PubMed ID: 16705055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy.
    Xiang Y; Huang J
    Acta Pharmacol Sin; 2000 Sep; 21(9):850-4. PubMed ID: 11501170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inducible NOS inhibition, eicosapentaenoic acid supplementation, and angiotensin II-induced renal damage.
    Theuer J; Shagdarsuren E; Muller DN; Kaergel E; Honeck H; Park JK; Fiebeler A; Dechend R; Haller H; Luft FC; Schunck WH
    Kidney Int; 2005 Jan; 67(1):248-58. PubMed ID: 15610248
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppressive treatment protects against angiotensin II-induced renal damage.
    Muller DN; Shagdarsuren E; Park JK; Dechend R; Mervaala E; Hampich F; Fiebeler A; Ju X; Finckenberg P; Theuer J; Viedt C; Kreuzer J; Heidecke H; Haller H; Zenke M; Luft FC
    Am J Pathol; 2002 Nov; 161(5):1679-93. PubMed ID: 12414515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deletion of angiotensin II type 2 receptor exaggerated atherosclerosis in apolipoprotein E-null mice.
    Iwai M; Chen R; Li Z; Shiuchi T; Suzuki J; Ide A; Tsuda M; Okumura M; Min LJ; Mogi M; Horiuchi M
    Circulation; 2005 Sep; 112(11):1636-43. PubMed ID: 16145000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardioprotective effect of angiotensin II type 1 receptor antagonist associated with bradykinin-endothelial nitric oxide synthase and oxidative stress in Dahl salt-sensitive hypertensive rats.
    Yoshida K; Kobayashi N; Ohno T; Fukushima H; Matsuoka H
    J Hypertens; 2007 Aug; 25(8):1633-42. PubMed ID: 17620960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of valsartan on the expression of angiotensin II receptors in the lung of chronic antigen exposure rats.
    Wang T; Yin KS; Liu KY; Lu GJ; Li YH; Chen JD
    Chin Med J (Engl); 2008 Nov; 121(22):2312-9. PubMed ID: 19080339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Downregulation of the cardiotrophin-1 gene expression by valsartan and spironolactone in hypertrophied heart rats in vivo and rat cardiomyocyte H9c2 cell line in vitro: a novel mechanism of cardioprotection.
    Al-Mazroua HA; Al-Rasheed NM; Korashy HM
    J Cardiovasc Pharmacol; 2013 Apr; 61(4):337-44. PubMed ID: 23288202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.